We founded the Swiss Ventures Group because the wealth of experience we have accumulated over the years is meant to be shared. Check out our news and find extensive background information on investments, startups and the world of VC.
Medtech startup GlucoSet, whose innovative ICU monitoring solutions enable hospitals to reduce complications and costs, raises €6M in series A, led by our Swiss Diabetes Venture Fund. Congrats to the GlucoSet team on this achievement.
Our Serpentine Ventures portfolio company and alt seafood startup, Impact Food, partners with Pokeworks to introduce its flagship plant-based tuna, offering sustainable and delicious alternative seafood options to a wider audience.
New study predicts that over 1.3bn adults will have diabetes by 2050, highlighting the important work of our portfolio companies within our Swiss Diabetes Venture Fund and the need for investment in cutting-edge diabetes technology.
Our Serpentine Ventures portfolio company Idun Technologies introduces revolutionary headphones that can measure brainwaves, offering unprecedented insights into mental states. Explore the potential of these headphones in this article.